Terapia con cellule staminali dell'epilessia .

L'epilessia come uno dei disturbi neurologici più comuni colpisce più di 50 milioni di persone in tutto il mondo con un tasso di prevalenza più elevato nei paesi a basso reddito. Scariche elettriche eccessive nei neuroni in seguito al danno o alla perdita delle cellule neurali causano convulsioni ricorrenti. One of the most common and difficult to treat types of epilepsy is temporal lobe epilepsy (TLE) which results from hippocampal sclerosis. Nowadays, similar to other diseases, epilepsy also is a candidate for treatment with different types of stem cells.

Various stem cell types were used for treatment of epilepsy in basic and experimental researches.

Two Terapia con cellule staminali has been shown efficacious in treating experimental models of neurological disorders, including Parkinson’s disease, and neuropsychiatric diseases, such as depression

Major roles of terapia con cellule staminali in epilepsy are prophylaxis against chronic epilepsy and amelioration cognitive function after the occurrence of TLE.

Cellule staminali pluripotenti indotte (iPSC)
Some epilepsies are caused because of a genetic mutation or change in neurons. Per esempio, Dravet syndrome is a devastating form of childhood epilepsy caused by a mutation in a specific sodium channel.
Scientists have found a way to take stem cells from people with Dravet syndrome and program them to become any type of cell in the body. These new cell types are called pluripotent stem cells. These new cells can be made into neurons.

Although much more research needs to be done, terapia con cellule staminali is an attractive and promising treatment for epilepsy.

Dettagli: head_office@nbscience.com

Clinica delle cellule staminali, Kiev, Ucraina

terapia con cellule staminali